JM

Jayeshkumar Manharlal Bhavsar

Active Director Director DIN 10760873
DIN 10760873 First appointment Aug 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Jayeshkumar Manharlal Bhavsar

Data last updated:

Jayeshkumar Manharlal Bhavsar is a Director at Mhdv Pharmaceuticals Private Limited (since 2024). The company operates in Paper.

DIN 10760873
Primary Designation Director
Industry Paper
First Appointment 30 Aug 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mhdv Pharmaceuticals Private Limited U21002GJ2024PTC154822
Director30 Aug 20242024Active

Board colleagues of Jayeshkumar Manharlal Bhavsar

Directorship timeline

Open interactive timeline →
Mhdv Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jayeshkumar Manharlal Bhavsar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jayeshkumar Manharlal Bhavsar

Jayeshkumar Manharlal Bhavsar currently holds 1 directorship: Mhdv Pharmaceuticals Private Limited (Director, since 30 Aug 2024).

Jayeshkumar Manharlal Bhavsar was first appointed on 30 Aug 2024 as Director at Mhdv Pharmaceuticals Private Limited.

The current boards of Jayeshkumar Manharlal Bhavsar's companies include Riteshkumar Madanlal Panjabi (Mhdv Pharmaceuticals Private Limited), Tejashkumar Maganbhai Patel (Mhdv Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available